France-based Enterome and Memorial Sloan Kettering Cancer Center have teamed up to evaluate the potential of gut microbiome-derived antigens for development as potential cancer immunotherapies.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,